---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-012616"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2025-03-13T23:59:59+00:00"
generated_at: "2026-05-24T21:20:11.524264+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# The Joint Corp reports Q4 revenue up 14%, 2025 guidance for lower EBITDA

## Summary
- Q4 revenue from continuing operations $14.4M (+14% YoY); net income $986k vs loss $10.2M.
- System-wide sales $145.2M (+9% Q4), comp sales 6%. Full-year sales $530.3M (+9%).
- 2025 guidance: system-wide sales $550-570M, consolidated adj EBITDA $10-11.5M vs $11.4M in 2024.
- New franchised clinic openings expected 30-40 in 2025 vs 57 in 2024; refranchising of corp clinics ongoing.
- Comp plan amended: CEO STIP max up to 125% base salary if EBITDA exceeds budget; CFO up to 62.5%.

## SEC filing metadata
- accession: 0001628280-25-012616
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2025-03-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000162828025012616/0001628280-25-012616-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000162828025012616/jynt-20250313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-012616
- JSON: https://secwatch.observer/filing/0001628280-25-012616.json
- Plain text: https://secwatch.observer/filing/0001628280-25-012616.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.